Characterization of Circular RNA Expression Profiles in Colon Specimens of Patients with Slow Transit Constipation

Changlei Xi1,2, Yuntian Hong1,3,4,5,6, Baoxiang Chen1,3,4,5,6

  • 1Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.

Disease Markers
|June 22, 2022
PubMed
Abstract

Insights

This study identified 190 differentially expressed circular RNAs (circRNAs) in slow transit constipation (STC) patients, suggesting a link between muscle-related pathways and STC pathogenesis. These findings offer potential biomarkers for STC diagnosis and treatment.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Genetics

Background:

  • Slow transit constipation (STC) is a condition of delayed colonic transit and reduced defecation urge.
  • Circular RNAs (circRNAs) are emerging as key regulators and biomarkers in various diseases.
  • The role of circRNAs in human STC tissues remains largely unexplored.

Purpose of the Study:

  • To investigate the circRNA expression profiles in human STC colon tissues.
  • To identify differentially expressed circRNAs (DE-circRNAs) and their potential roles in STC pathogenesis.
  • To construct circRNA-microRNA-mRNA regulatory networks for STC.

Main Methods:

  • High-throughput RNA sequencing was employed to compare circRNA expression between STC patients and controls.
  • Bioinformatics analyses were conducted on DE-circRNAs and their host genes.
  • Quantitative real-time polymerase chain reaction (qRT-PCR) was used to validate DE-circRNA expression levels.

Main Results:

  • 190 DE-circRNAs were identified in STC colon samples.
  • Bioinformatics analysis indicated enrichment in muscle-related pathways, suggesting a link between muscle diseases and STC.
  • circRNA-microRNA-mRNA networks revealed potential regulatory mechanisms involving smooth muscle function.

Conclusions:

  • This study presents a comprehensive circRNA expression profile in STC.
  • Identified DE-circRNAs serve as potential candidates for further research into STC pathogenesis.
  • The findings provide a foundation for developing novel diagnostic biomarkers and therapeutic targets for STC.